HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Government Will Conduct Abortion Pill Review Amid Studies Showing Possible Dangers A recent report shows that more than 1 in 10 women experience adverse side effects from chemical abortions.

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the abortion pill, mifepristone, amid queries from Congress. Sen. Josh Hawley (R-MO) ...